Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 AEP621 | DOI: 10.1530/endoabs.73.AEP621

1Hospital Universitary Reina Sofía, Endocrinology, Cordoba, Spain


Objective

Health care for transsexuals has changed in Andalucia since 2014. Our unit of attention to transsexual people began in 2015. The objective of this study is to analyze our experience.

Patients and methods

Retrospective study by reviewing the medical records of the transsexuals treated in our unit.

Results

145 transsexual people. Transsexual man to woman (TMW): 44.1%, Transsexual woman to man (TWM): 55.9%. 27.97 ± 8.14 years old. Start cross hormonal treatment 88.3%, 5 people have abandoned the treatment (4.8%): 1 planned pregnancy, 2 repentance, 2 another disease. Treatment complications have not been detected. Sex reassignment surgery: 41.5% (n = 54). TMW: 10 hysterectomy-oophorectomy and mastectomy, 16 hysterectomy-oophorectomy and mastectomy at same time (uncomplicated and preferred by people), 1 hysterectomy-oophorectomy, mastectomy and phalloplasty, 22 only mastectomy. TWM: 11 mammoplasty, 5 mammoplasty and feminizing genitoplasty. Private surgical intervention: 66.7%.

Conclusions

TWM is slightly more frequent in our series. Most people consult in the second decade of life, and most of them start cross hormonal treatment. Abandonment of cross hormonal treatment is uncommon. Treatment complications have not been detected. Only half of the people who start treatment have undergone sex reassignment surgery, half in the public health system. Hysterectomy-oophorectomy and mastectomy at same time has not more complications and it´s preferred by people.

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

Authors